SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-23-002120
Filing Date
2023-11-14
Accepted
2023-11-14 17:00:41
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e5207_10q.htm   iXBRL 10-Q 783384
2 EXHIBIT 10.3 e5207_ex10-3.htm EX-10.3 231249
3 EXHIBIT 31.1 e5207_ex31-1.htm EX-31.1 8480
4 EXHIBIT 31.2 e5207_ex31-2.htm EX-31.2 8518
5 EXHIBIT 32.1 e5207_ex32-1.htm EX-32.1 5056
6 EXHIBIT 32.2 e5207_ex32-2.htm EX-32.2 5143
  Complete submission text file 0001731122-23-002120.txt   5105076

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE renb-20230930.xsd EX-101.SCH 42730
8 XBRL CALCULATION FILE renb-20230930_cal.xml EX-101.CAL 46054
9 XBRL DEFINITION FILE renb-20230930_def.xml EX-101.DEF 165922
10 XBRL LABEL FILE renb-20230930_lab.xml EX-101.LAB 325469
11 XBRL PRESENTATION FILE renb-20230930_pre.xml EX-101.PRE 276637
56 EXTRACTED XBRL INSTANCE DOCUMENT e5207_10q_htm.xml XML 632350
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 231407697
SIC: 2834 Pharmaceutical Preparations